Doctor profile · Federal record
Dr. Marcia Brose, MD
Medical Oncology Physician (CMS: Medical Oncology) · Otolaryngology Physician · Philadelphia, PA
- NPI 1316975451
- Accepts Medicare
- 31 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10800 Knights RD Fl 3
Philadelphia, PA 191144200
(215) 890-3030
fax (215) 890-3031 - Mailing address
-
1101 Market St Fl 30
Philadelphia, PA 191072934
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- November 17, 2021
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Pennsylvania #MD063022L
- Medicaid
- PA #0019057620001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316975451. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
347
Distinct HCPCS
3
Medicare allowed
$59,798
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 252 | 95 | $185 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 84 | 60 | $133 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 11 | 11 | $178 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 121. This provider delivers 2.9× the peer median.Open Payments
Industry payments received
All-time total
$34,187
Transactions
21
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Eisai Co., Ltd. | 4 | $15,676.13 | |
| Eisai Inc. | 7 | $15,400.76 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $2,450.00 | |
| Exelixis Inc. | 5 | $408.65 | |
| Galvanize Therapeutics, Inc | 2 | $202.75 | |
| Gilead Sciences, Inc. | 1 | $25.92 | |
| Celgene Corporation | 1 | $22.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
544
Patients
77
Total drug cost
$5,505,074
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Lenvima (Lenvatinib Mesylate) | Brand | 173 | 21 | $4,219,113 |
| Levothyroxine Sodium | Generic | 138 | 43 | $4,231 |
| Synthroid (Levothyroxine Sodium) | Brand | 38 | 13 | $4,122 |
| Amlodipine Besylate | Generic | 28 | 0 | $358 |
| Cabometyx (Cabozantinib S-Malate) | Brand | 24 | 0 | $1,255,972 |
| Lorazepam | Generic | 20 | 0 | $222 |
| Lisinopril | Generic | 18 | 0 | $506 |
| Alprazolam | Generic | 16 | 0 | $126 |
| Oxycodone Hcl | Generic | 16 | 0 | $236 |
| Gabapentin | Generic | 13 | 0 | $218 |
Frequently asked questions
What is Dr. Marcia Brose's medical specialty?
Dr. Marcia Brose practices Medical Oncology Physician in Philadelphia, PA.
Where does Dr. Marcia Brose practice?
Dr. Marcia Brose practices at 10800 Knights RD Fl 3, Philadelphia, PA 191144200. Office phone: 2158903030.
What is Dr. Marcia Brose's NPI?
Dr. Marcia Brose's National Provider Identifier (NPI) is 1316975451, issued by NPPES.
Does Dr. Marcia Brose accept Medicare assignment?
Yes. Dr. Marcia Brose accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Marcia Brose commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.